APA (7th ed.) Citation

TA, H., X, W., TE, S., J, G., MV, K., M, W., . . . EE, V. (2021). Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC. JTO clinical and research reports, 2(8), 100208. https://doi.org/10.1016/j.jtocrr.2021.100208

Chicago Style (17th ed.) Citation

TA, Hensing, et al. "Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC." JTO Clinical and Research Reports 2, no. 8 (2021): 100208. https://doi.org/10.1016/j.jtocrr.2021.100208.

MLA (9th ed.) Citation

TA, Hensing, et al. "Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC." JTO Clinical and Research Reports, vol. 2, no. 8, 2021, p. 100208, https://doi.org/10.1016/j.jtocrr.2021.100208.